University College Dublin - formally known as University College Dublin - National University of Ireland, Dublin is Ireland's largest, and the island of Ireland's second largest, university, with over 1,300 faculty and 17,000 undergraduate students. It is located in Dublin, the Irish capital. Wikipedia.
University College Dublin and Foundation Scholars And The Other Members Of Board | Date: 2016-06-28
(E)-2-(2-Quinolin-2-yl-propenyl)-phenol, 2-Quinolin-2-yl-ylethynyl-phenol and salts thereof are useful as medicaments, especially for treatment of an angiogenesis-related disease or disorder.
University College Dublin | Date: 2016-11-11
The invention generally relates to compounds that function as TP antagonists for treating thrombosis and other cardiovascular, renal, or pulmonary diseases. In some embodiments, the invention provides a compound including a substituted nitro phenoxy phenyl, a sulfonylurea, and an alkyl group. In some embodiments, the invention provides a method of treating thrombosis by administering an antithrombotic compound that preferentially binds to a thromboxane receptor, has preferential binding for either TPalpha (TP) or TPbeta (TP) receptor subtype.
University College Dublin and Foundation Scholars And The Other Members Of Board | Date: 2017-03-29
University College Dublin | Date: 2017-03-22
A composition comprising a silica-based nanobead having its surface functionalized by a moiety selected from moieties that are reactive to and combine with a fouling layer on a material surface.
University College Dublin and University of Limerick | Date: 2017-03-22
A peptide having 12 to 60 amino acids and including (a) a sequence of SEQUENCE ID NO: 11, or (b) a fragment of SEQUENCE ID NO: 11 that includes the sequence of SEQUENCE ID NO: 1 or 5, is described for use in improving glycemic management in a mammal. A composition, for example a food product, that includes substantially all of the peptides of SEQUENCE ID NO:s 1 to 11, that is capable of reducing post-prandial blood glucose levels, and increasing insulin secretion in humans, is also described.
Agency: European Commission | Branch: H2020 | Program: SGA-RIA | Phase: FETFLAGSHIP | Award Amount: 89.00M | Year: 2016
This project is the second in the series of EC-financed parts of the Graphene Flagship. The Graphene Flagship is a 10 year research and innovation endeavour with a total project cost of 1,000,000,000 euros, funded jointly by the European Commission and member states and associated countries. The first part of the Flagship was a 30-month Collaborative Project, Coordination and Support Action (CP-CSA) under the 7th framework program (2013-2016), while this and the following parts are implemented as Core Projects under the Horizon 2020 framework. The mission of the Graphene Flagship is to take graphene and related layered materials from a state of raw potential to a point where they can revolutionise multiple industries. This will bring a new dimension to future technology a faster, thinner, stronger, flexible, and broadband revolution. Our program will put Europe firmly at the heart of the process, with a manifold return on the EU investment, both in terms of technological innovation and economic growth. To realise this vision, we have brought together a larger European consortium with about 150 partners in 23 countries. The partners represent academia, research institutes and industries, which work closely together in 15 technical work packages and five supporting work packages covering the entire value chain from materials to components and systems. As time progresses, the centre of gravity of the Flagship moves towards applications, which is reflected in the increasing importance of the higher - system - levels of the value chain. In this first core project the main focus is on components and initial system level tasks. The first core project is divided into 4 divisions, which in turn comprise 3 to 5 work packages on related topics. A fifth, external division acts as a link to the parts of the Flagship that are funded by the member states and associated countries, or by other funding sources. This creates a collaborative framework for the entire Flagship.
Agency: European Commission | Branch: H2020 | Program: ECSEL-IA | Phase: ECSEL-17-2015 | Award Amount: 64.82M | Year: 2016
ENABLE-S3 will pave the way for accelerated application of highly automated and autonomous systems in the mobility domains automotive, aerospace, rail and maritime as well as in the health care domain. Virtual testing, verification and coverage-oriented test selection methods will enable validation with reasonable efforts. The resulting validation framework will ensure Europeans Industry competitiveness in the global race of automated systems with an expected market potential of 60B in 2025. Project results will be used to propose standardized validation procedures for highly automated systems (ACPS). The technical objectives addressed are: 1. Provision of a test and validation framework that proves the functionality, safety and security of ACPS with at least 50% less test effort than required in classical testing. 2. Promotion of a new technique for testing of automated systems with physical sensor signal stimuli generators, which will be demonstrated for at least 3 physical stimuli generators. 3. Raising significantly the level of dependability of automated systems due to provision of a holistic test and validation platform and systematic coverage measures, which will reduce the probability of malfunction behavior of automated systems to 10E-9/h. 4. Provision of a validation environment for rapid re-qualification, which will allow reuse of validation scenarios in at least 3 development stages. 5. Establish open standards to speed up the adoption of the new validation tools and methods for ACPS. 6. Enabling safe, secure and functional ACPS across domains. 7. Creation of an eco-system for the validation and verification of automated systems in the European industry. ENABLE-S3 is strongly industry-driven. Realistic and relevant industrial use-cases from smart mobility and smart health will define the requirements to be addressed and assess the benefits of the technological progress.
McGettigan P.A.,University College Dublin
Current Opinion in Chemical Biology | Year: 2013
The transcriptomics field has developed rapidly with the advent of next-generation sequencing technologies. RNA-seq has now displaced microarrays as the preferred method for gene expression profiling.The comprehensive nature of the data generated has been a boon in terms of transcript identification but analysis challenges remain. Key among these problems is the development of suitable expression metrics for expression level comparisons and methods for identification of differentially expressed genes (and exons). Several approaches have been developed but as yet no consensus exists on the best pipeline to use.De novo transcriptome approaches are increasingly viable for organisms lacking a sequenced genome. The reduction in starting RNA required has enabled the development of new applications such as single cell transcriptomics.The emerging picture of mammalian transcription is complex with further refinement expected with the integration of epigenomic data generated by projects such as ENCODE. © 2013 Elsevier Ltd.
Albrecht M.,University College Dublin
Chemical Reviews | Year: 2010
A study was conducted some of the fundamental aspects and the latest trends in the field of cyclometalation using d-block transition metals. It was revealed that cyclometalation had emerged as one of the most popular organometallic reactions, providing a simple entry to organometallic compounds. It allowed for the investigation of the essential aspects governing the metal-mediated activation of unreactive bonds, such as the C-H bond. The study covered seminal fundamental literature and the latest highlights and the trends that emerged till early 2009. Cyclometalation gained significance due to the reaction representing the mildest route for achieving strong C-H and C-R bonds. It had also emerged as an attractive and versatile synthetic method for creating organometallic entities with significantly wide application potential.
Braun H.-B.,University College Dublin
Advances in Physics | Year: 2012
Micromagnetics has been the method of choice to interpret experimental data in the area of microscopic magnetism for several decades. In this article, we show how progress has been made to extend this formalism to include thermal and quantum fluctuations in order to describe recent experimental developments in nanoscale magnetism. For experimental systems with constrained dimensions such as nanodots, atomic chains, nanowires, and thin films, topological defects such as solitons, vortices, skyrmions, and monopoles start to play an increasingly important role, all forming novel types of quasiparticles in patterned low-dimensional magnetic systems. We discuss in detail how soliton-antisoliton pairs of opposite chirality form non-uniform energy barriers against thermal fluctuations in nanowires or pillars. As a consequence of their low barrier energy compared to uniform reversal, they limit the thermal stability of perpendicular recording media. For sufficiently short samples, the non-uniform energy barrier continuously merges into the conventional uniform Néel-Brown barrier. Partial formation of chiral domain walls also determines the magnetic properties of granular nanostructured magnets and exchange spring systems. For a long time, the reconciliation between micromagnetics and quantum mechanics has remained an unresolved challenge. Here it is demonstrated how inclusion of Berry's phase in a micromagnetic action allows for a semiclassical quantization of spin systems, a method that is demonstrated by the simple example of an easy-plane spin. This powerful method allows for a description of quantum dynamics of solitons and breathers which in the latter case agrees with the anisotropic spin-XYZ-model. The domain wall or soliton chirality plays an important role as it is coupled to the wavevector of the quasiparticle dispersion. We show how this quantum soliton chirality is detected by polarized neutron scattering in one-dimensional quantum antiferromagnets. © 2012 Taylor & Francis.